{"id":"https://openalex.org/W2413552575","doi":"https://doi.org/10.14227/dt230216p30","title":"Discriminatory Dissolution Method Development and Validation of Etoricoxib Tablets","display_name":"Discriminatory Dissolution Method Development and Validation of Etoricoxib Tablets","publication_year":2016,"publication_date":"2016-01-01","ids":{"openalex":"https://openalex.org/W2413552575","doi":"https://doi.org/10.14227/dt230216p30","mag":"2413552575"},"language":"en","primary_location":{"id":"doi:10.14227/dt230216p30","doi":"https://doi.org/10.14227/dt230216p30","is_oa":true,"landing_page_url":"https://doi.org/10.14227/dt230216p30","pdf_url":"https://doi.org/10.14227/dt230216p30","source":{"id":"https://openalex.org/S98185054","display_name":"Dissolution Technologies","issn_l":"1521-298X","issn":["1521-298X","2376-869X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","poland-40","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dissolution Technologies","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://doi.org/10.14227/dt230216p30","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064334363","display_name":"Yasvanth Ashokraj","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133301","display_name":"Cipla (India)","ror":"https://ror.org/02w6dqa48","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210133301"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Yasvanth Ashokraj","raw_affiliation_strings":["CIPLA Ltd, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIPLA Ltd, Mumbai, India","institution_ids":["https://openalex.org/I4210133301"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075295347","display_name":"Atul Daroi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133301","display_name":"Cipla (India)","ror":"https://ror.org/02w6dqa48","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210133301"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Atul Daroi","raw_affiliation_strings":["CIPLA Ltd, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIPLA Ltd, Mumbai, India","institution_ids":["https://openalex.org/I4210133301"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081020940","display_name":"Raja Gupta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133301","display_name":"Cipla (India)","ror":"https://ror.org/02w6dqa48","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210133301"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Raja Gupta","raw_affiliation_strings":["CIPLA Ltd, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIPLA Ltd, Mumbai, India","institution_ids":["https://openalex.org/I4210133301"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071058784","display_name":"Aruna Khanolkar","orcid":"https://orcid.org/0009-0002-7931-1938","observed_orcids":["https://orcid.org/0009-0002-7931-1938"]},"institutions":[{"id":"https://openalex.org/I4210133301","display_name":"Cipla (India)","ror":"https://ror.org/02w6dqa48","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210133301"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Aruna Khanolkar","raw_affiliation_strings":["CIPLA Ltd, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIPLA Ltd, Mumbai, India","institution_ids":["https://openalex.org/I4210133301"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023809091","display_name":"Amol Kulkarni","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133301","display_name":"Cipla (India)","ror":"https://ror.org/02w6dqa48","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210133301"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Amol Kulkarni","raw_affiliation_strings":["CIPLA Ltd, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIPLA Ltd, Mumbai, India","institution_ids":["https://openalex.org/I4210133301"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5097566684","display_name":"Swat Laud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133301","display_name":"Cipla (India)","ror":"https://ror.org/02w6dqa48","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210133301"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Swat Laud","raw_affiliation_strings":["CIPLA Ltd, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIPLA Ltd, Mumbai, India","institution_ids":["https://openalex.org/I4210133301"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057819536","display_name":"Milind Pokale","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133301","display_name":"Cipla (India)","ror":"https://ror.org/02w6dqa48","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210133301"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Milind Pokale","raw_affiliation_strings":["CIPLA Ltd, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIPLA Ltd, Mumbai, India","institution_ids":["https://openalex.org/I4210133301"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062987264","display_name":"Sanjeet Shedge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133301","display_name":"Cipla (India)","ror":"https://ror.org/02w6dqa48","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210133301"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Sanjeet Shedge","raw_affiliation_strings":["CIPLA Ltd, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIPLA Ltd, Mumbai, India","institution_ids":["https://openalex.org/I4210133301"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038173678","display_name":"Praveen Date","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210133301","display_name":"Cipla (India)","ror":"https://ror.org/02w6dqa48","country_code":"IN","type":"company","lineage":["https://openalex.org/I4210133301"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Praveen Date","raw_affiliation_strings":["CIPLA Ltd, Mumbai, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CIPLA Ltd, Mumbai, India","institution_ids":["https://openalex.org/I4210133301"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5064334363"],"corresponding_institution_ids":["https://openalex.org/I4210133301"],"apc_list":null,"apc_paid":null,"fwci":1.2227,"has_fulltext":true,"cited_by_count":21,"citation_normalized_percentile":{"value":0.72680269,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"23","issue":"2","first_page":"30","last_page":"34"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9146000146865845,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9146000146865845,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.07750000059604645,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12878","display_name":"Pharmaceutical Quality and Counterfeiting","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/etoricoxib","display_name":"etoricoxib","score":0.9959999918937683},{"id":"https://openalex.org/keywords/method-validation","display_name":"method validation","score":0.640999972820282},{"id":"https://openalex.org/keywords/ph-dependent-solubility","display_name":"pH-dependent solubility","score":0.8339999914169312},{"id":"https://openalex.org/keywords/tablets","display_name":"tablets","score":0.5630000233650208},{"id":"https://openalex.org/keywords/quality-by-design","display_name":"quality by design","score":0.7900000214576721},{"id":"https://openalex.org/keywords/methodological-robustness","display_name":"method robustness","score":0.7160000205039978},{"id":"https://openalex.org/keywords/methodological-variation","display_name":"methodological variability","score":0.6019999980926514},{"id":"https://openalex.org/keywords/method-reproducibility","display_name":"method reproducibility","score":0.6899999976158142}],"concepts":[{"id":"https://openalex.org/C2776214540","wikidata":"https://www.wikidata.org/wiki/Q631202","display_name":"Etoricoxib","level":2,"score":0.9683299660682678},{"id":"https://openalex.org/C88380143","wikidata":"https://www.wikidata.org/wiki/Q416674","display_name":"Dissolution","level":2,"score":0.5306847095489502},{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.502483606338501},{"id":"https://openalex.org/C14029885","wikidata":"https://www.wikidata.org/wiki/Q5282807","display_name":"Dissolution testing","level":4,"score":0.4347699284553528},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.39325007796287537},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3352029323577881},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.33262598514556885},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.32213395833969116},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.21555837988853455},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.0},{"id":"https://openalex.org/C147789679","wikidata":"https://www.wikidata.org/wiki/Q11372","display_name":"Physical chemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.14227/dt230216p30","doi":"https://doi.org/10.14227/dt230216p30","is_oa":true,"landing_page_url":"https://doi.org/10.14227/dt230216p30","pdf_url":"https://doi.org/10.14227/dt230216p30","source":{"id":"https://openalex.org/S98185054","display_name":"Dissolution Technologies","issn_l":"1521-298X","issn":["1521-298X","2376-869X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","poland-40","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dissolution Technologies","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.14227/dt230216p30","doi":"https://doi.org/10.14227/dt230216p30","is_oa":true,"landing_page_url":"https://doi.org/10.14227/dt230216p30","pdf_url":"https://doi.org/10.14227/dt230216p30","source":{"id":"https://openalex.org/S98185054","display_name":"Dissolution Technologies","issn_l":"1521-298X","issn":["1521-298X","2376-869X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","poland-40","russia-white-list-3"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Dissolution Technologies","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2413552575.pdf","grobid_xml":"https://content.openalex.org/works/W2413552575.grobid-xml"},"referenced_works_count":8,"referenced_works":["https://openalex.org/W1522767714","https://openalex.org/W1964906039","https://openalex.org/W1989290224","https://openalex.org/W1996929770","https://openalex.org/W2027084906","https://openalex.org/W2161760407","https://openalex.org/W2945792041","https://openalex.org/W4236145016"],"related_works":["https://openalex.org/W3200855729","https://openalex.org/W2968389687","https://openalex.org/W2944461805","https://openalex.org/W2510704496","https://openalex.org/W2391884827","https://openalex.org/W3131345277","https://openalex.org/W2996255338","https://openalex.org/W6893212507","https://openalex.org/W2368353083","https://openalex.org/W2223276738"],"abstract_inverted_index":{"The":[0],"availability":[1],"of":[2,36,69],"a":[3,37,43],"discriminatory":[4,38],"dissolution":[5,39],"method":[6,40,62,72],"for":[7,24,27,41,61],"use":[8],"in":[9,17],"either":[10],"quality":[11,18],"control":[12],"testing":[13],"or":[14],"product":[15],"evaluation":[16],"by":[19],"design":[20],"trials":[21],"is":[22],"mandatory":[23],"products":[25],"intended":[26],"the":[28,33,70],"developed":[29,71],"market.This":[30],"study":[31],"demonstrates":[32],"systematic":[34],"development":[35],"etoricoxib,":[42],"BCS":[44],"Class":[45],"2":[46],"drug":[47],"exhibiting":[48],"highly":[49],"pHdependent":[50],"solubility.The":[51],"pH,":[52],"speed,":[53],"and":[54,59,65],"apparatus":[55],"were":[56],"simultaneously":[57],"optimized":[58],"tested":[60],"variability,":[63],"reproducibility,":[64],"robustness.The":[66],"discriminative":[67],"power":[68],"was":[73],"suitably":[74],"demonstrated.":[75]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":4},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}